These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 29037499

  • 1. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C, Assogna F, Cellupica N, Piras F, Pierantozzi M, Stefani A, Cerroni R, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [Abstract] [Full Text] [Related]

  • 2. Alexithymia and anhedonia in early Richardson's syndrome and progressive supranuclear palsy with predominant parkinsonism.
    Assogna F, Pellicano C, Cravello L, Savini C, Macchiusi L, Pierantozzi M, Stefani A, Mercuri B, Caltagirone C, Pontieri FE, Spalletta G.
    Brain Behav; 2019 Dec; 9(12):e01448. PubMed ID: 31743601
    [Abstract] [Full Text] [Related]

  • 3. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G, Cuoco S, Pellecchia MT, Erro R, Barone P, Picillo M.
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [Abstract] [Full Text] [Related]

  • 4. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ, Wieczorek D, Konkel A, Dąbrowska M, Sławek J.
    Psychiatr Pol; 2017 Aug 29; 51(4):647-659. PubMed ID: 28987055
    [Abstract] [Full Text] [Related]

  • 5. Qualitative evaluation of the Rey-Osterrieth Complex Figure Test in patients with progressive supranuclear palsy.
    Tommasini L, Bonaccorsi J, Del Prete E, Cintoli S, Pagni C, Mazzucchi S, Palermo G, Morganti R, Frosini D, Siciliano G, Tognoni G, Ceravolo R.
    Clin Neuropsychol; 2023 Aug 29; 37(6):1207-1220. PubMed ID: 35997036
    [Abstract] [Full Text] [Related]

  • 6. In vivo comparison of Richardson's syndrome and progressive supranuclear palsy-parkinsonism.
    Srulijes K, Mallien G, Bauer S, Dietzel E, Gröger A, Ebersbach G, Berg D, Maetzler W.
    J Neural Transm (Vienna); 2011 Aug 29; 118(8):1191-7. PubMed ID: 21207078
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease.
    Zanigni S, Calandra-Buonaura G, Manners DN, Testa C, Gibertoni D, Evangelisti S, Sambati L, Guarino M, De Massis P, Gramegna LL, Bianchini C, Rucci P, Cortelli P, Lodi R, Tonon C.
    Neuroimage Clin; 2016 Aug 29; 11():736-742. PubMed ID: 27330973
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M, Seppi K, Mueller C, Potrusil T, Goebel G, Reiter E, Nocker M, Steiger R, Wildauer M, Gizewski ER, Wenning GK, Poewe W, Scherfler C.
    Parkinsonism Relat Disord; 2018 Apr 29; 49():81-87. PubMed ID: 29463454
    [Abstract] [Full Text] [Related]

  • 9. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A, Pagonabarraga J, Martínez-Horta S, Busteed L, Pascual-Sedano B, Illán-Gala I, Marin-Lahoz J, Aracil-Bolaños I, Pérez-Pérez J, Sampedro F, Bejr-Kasem H, Kulisevsky J.
    J Neurol; 2021 Sep 29; 268(9):3400-3408. PubMed ID: 33704556
    [Abstract] [Full Text] [Related]

  • 10. Frontal deficits differentiate progressive supranuclear palsy from Parkinson's disease.
    Lee YE, Williams DR, Anderson JF.
    J Neuropsychol; 2016 Mar 29; 10(1):1-14. PubMed ID: 25223526
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ.
    Brain; 2005 Jun 29; 128(Pt 6):1247-58. PubMed ID: 15788542
    [Abstract] [Full Text] [Related]

  • 12. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A, Morelli M, Nigro S, Quattrone A, Vescio B, Arabia G, Nicoletti G, Nisticò R, Salsone M, Novellino F, Barbagallo G, Le Piane E, Pugliese P, Bosco D, Vaccaro MG, Chiriaco C, Sabatini U, Vescio V, Stanà C, Rocca F, Gullà D, Caracciolo M.
    Parkinsonism Relat Disord; 2018 Sep 29; 54():3-8. PubMed ID: 30068492
    [Abstract] [Full Text] [Related]

  • 13. Levodopa modulates semantic fluency and uniqueness in non-demented patients with progressive supranuclear palsy.
    Ma J, Zhang G, Zhao Z, Chan P, Ye Z.
    Brain Behav; 2024 Jul 29; 14(7):e3606. PubMed ID: 38945805
    [Abstract] [Full Text] [Related]

  • 14. Neuropsychological assessment could distinguish among different clinical phenotypes of progressive supranuclear palsy: A Machine Learning approach.
    Vaccaro MG, Sarica A, Quattrone A, Chiriaco C, Salsone M, Morelli M, Quattrone A.
    J Neuropsychol; 2021 Sep 29; 15(3):301-318. PubMed ID: 33231380
    [Abstract] [Full Text] [Related]

  • 15. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
    Fiorenzato E, Antonini A, Camparini V, Weis L, Semenza C, Biundo R.
    J Neural Transm (Vienna); 2019 Nov 29; 126(11):1437-1445. PubMed ID: 31432258
    [Abstract] [Full Text] [Related]

  • 16. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S, Redaelli V, Soliveri P, Fetoni V, Barocco F, Caffarra P, Scaglioni A, Tramacere I, Girotti F.
    Cortex; 2018 Dec 29; 109():272-278. PubMed ID: 30399478
    [Abstract] [Full Text] [Related]

  • 17. The applause sign and neuropsychological profile in progressive supranuclear palsy and Parkinson's disease.
    Somme J, Gómez-Esteban JC, Tijero B, Berganzo K, Lezcano E, Zarranz JJ.
    Clin Neurol Neurosurg; 2013 Aug 29; 115(8):1230-3. PubMed ID: 23253819
    [Abstract] [Full Text] [Related]

  • 18. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M, Cuoco S, Tepedino MF, Cappiello A, Volpe G, Erro R, Santangelo G, Pellecchia MT, Barone P, PSP Salerno study group.
    J Neurol; 2019 Jul 29; 266(7):1727-1735. PubMed ID: 30989369
    [Abstract] [Full Text] [Related]

  • 19. Midbrain atrophy in patients with presymptomatic progressive supranuclear palsy-Richardson's syndrome.
    Ahn JH, Kim M, Kim JS, Youn J, Jang W, Oh E, Lee PH, Koh SB, Ahn TB, Cho JW.
    Parkinsonism Relat Disord; 2019 Sep 29; 66():80-86. PubMed ID: 31307918
    [Abstract] [Full Text] [Related]

  • 20. MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease.
    Longoni G, Agosta F, Kostić VS, Stojković T, Pagani E, Stošić-Opinćal T, Filippi M.
    Mov Disord; 2011 Feb 01; 26(2):247-55. PubMed ID: 21412831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.